Insurer Sues Litigation Funder Case Cash Over Alleged Inflated Personal-Injury Claims
A new lawsuit casts a harsh light on the consumer litigation funding model, with a major insurer accusing a New York funder of engineering a scheme to inflate personal injury claims at carriers' expense.
As reported by Insurance Business, New York Marine & General Insurance Company has sued Case Cash Funding and its principal, Gregory Elefterakis, a suspended attorney, in Manhattan federal court. The complaint, filed June 12, alleges that Case Cash advanced modest sums to injured claimants as "non-recourse" funding, then used its control over the claims to balloon them into multimillion-dollar demands.
According to the suit, the defendants paid referral fees to medical clinics, steered claimants toward favored attorneys, conditioned funding on claimants undergoing surgery, and blocked settlements that did not maximize their returns. In one instance, the parties had agreed on a $750,000 settlement, but the funder allegedly refused and asserted a lien of more than $1.4 million instead. The complaint cites a claimant who received just 13.3% of a $3.75 million settlement while the funder collected 47.5%, and another facing an effective interest rate of roughly 170%.
The filing also points to a securitization instrument, PEAR 2022-1, said to contain more than $84.6 million in receivables across nearly 16,807 advances—underscoring the scale of the operation. The case adds to mounting insurer pushback against consumer legal funding practices and feeds the broader debate over disclosure and regulation of the industry.







